245 related articles for article (PubMed ID: 10914933)
1. Treatment of the myeloproliferative disorders with 32P.
Berlin NI
Eur J Haematol; 2000 Jul; 65(1):1-7. PubMed ID: 10914933
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Dingli D; Tefferi A
Curr Hematol Malig Rep; 2006 Jun; 1(2):69-74. PubMed ID: 20425334
[TBL] [Abstract][Full Text] [Related]
3. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
5. [Efficacious treatment of a fatal blood disease: polycythemia vera].
Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
[No Abstract] [Full Text] [Related]
6. Use of radioactive phosphorus in haematology.
Roberts BE; Smith AH
Blood Rev; 1997 Sep; 11(3):146-53. PubMed ID: 9370045
[TBL] [Abstract][Full Text] [Related]
7. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
[TBL] [Abstract][Full Text] [Related]
8. EANM procedure guidelines for 32P therapy.
EANM
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):BP17-9. PubMed ID: 12723560
[No Abstract] [Full Text] [Related]
9. Treatment of polycythaemia vera and essential thrombocythaemia.
Tefferi A; Silverstein MN
Baillieres Clin Haematol; 1998 Dec; 11(4):769-85. PubMed ID: 10640216
[TBL] [Abstract][Full Text] [Related]
10. Essential thrombocythemia: response during first year of therapy with melphalan and radioactive phosphorus: a polycythemia Vera Study Group report.
Murphy S; Rosenthal DS; Weinfeld A; Briere J; Faguet GB; Knospe WH; Landaw SA; Laszlo J; Pisciotta AV; Tartaglia AP
Cancer Treat Rep; 1982 Jul; 66(7):1495-500. PubMed ID: 7046930
[TBL] [Abstract][Full Text] [Related]
11. The management of elderly patients with myeloproliferative disorders.
Tura S
Hematol Oncol; 1993; 11 Suppl 1():39-41. PubMed ID: 8486340
[No Abstract] [Full Text] [Related]
12. Therapeutic options for essential thrombocythemia and polycythemia vera.
Solberg LA
Semin Oncol; 2002 Jun; 29(3 Suppl 10):10-5. PubMed ID: 12096352
[TBL] [Abstract][Full Text] [Related]
13. Essential thrombocythemia following polycythemia vera: an unusual sequence.
Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
[TBL] [Abstract][Full Text] [Related]
14. [Essential thrombocythemia: conventional therapy].
Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
[No Abstract] [Full Text] [Related]
15. Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
Najean Y; Rain JD
Blood; 1997 Apr; 89(7):2319-27. PubMed ID: 9116275
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera: a retrospective and reprise.
Berlin NI; Wasserman LR
J Lab Clin Med; 1997 Oct; 130(4):365-73. PubMed ID: 9358074
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative diseases.
Silverstein MN
Postgrad Med; 1977 Feb; 61(2):206-10. PubMed ID: 556856
[TBL] [Abstract][Full Text] [Related]
18. [Chronic myeloproliferative diseases].
Sréter L
Orv Hetil; 1998 Jul; 139(30):1779-83. PubMed ID: 9718944
[TBL] [Abstract][Full Text] [Related]
19. Interferon in the treatment of myeloproliferative diseases.
Silver RT
Semin Hematol; 1990 Jul; 27(3 Suppl 4):6-14. PubMed ID: 2115694
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy of 32P-induced remission in polycythemia vera. A clinical trial of chlorambucil and hydroxy-urea in 109 cases.
Najean Y; Dresch C; Rain JD
Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):377-85. PubMed ID: 112580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]